Raza Bokhari, CEO and Director, acquired 805,802 Subordinate Voting Shares Class B on a direct ownership basis at a price of $3.102 through a prospectus or prospectus exempt offering on August 20th, 2020. This represents a $2,500,001 investment into the company's shares and an account share holdings change of greater than 100%.
Seven other insiders also reported acquiring shares on the same day on the same terms.
FSD Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
FSD Pharma Inc is a Canada-based company engaged in the cultivation of cannabis. The Company through its wholly owned subsidiary, FV Pharma, operates as an authorized licensed producer of cannabis for medical purposes (ACMPR). In addition, the Company also owns stakes in Canara, which specializes in indoor cultivation.
No Comments